Here are six takeaways:
1. More than 90 percent of life sciences and technology companies expect to increase their investment in digital healthcare.
2. Remote monitoring and mHealth will see growth over the next two decades.
3. The report revealed even if their products wouldn’t receive patent protection, 90 percent of technology companies and 82 percent of life sciences companies would implement a digital healthcare strategy.
4. Mergers and acquisitions attract 63 percent of technology companies and 50 percent of life science companies as strategies for succeeding in digital healthcare.
5. However, more than 80 percent of respondents reported life sciences and technology companies have “incompatible” business cultures that would stop them from joining forces to commercialize digital healthcare products.
6. The majority of executives cited intellectual property complications as obstacles to digital healthcare growth.
“Those committing financial and human resources to digital healthcare are creating new businesses that may give them a competitive advantage,” said Dimitrios Drivas, head of White & Case’s global intellectual property practice. “These companies are leading a global healthcare transformation that could vastly improve patient outcomes.”
More articles on practice management:
SCI Solutions acquires Clarity Health to create referral management powerhouse: 5 observations
What benefits do physician practices offer employees? 13 statistics
7 trends on physician compensation in 2015
